- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 16.32M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $3.42M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.3M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.08M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.44M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $38.09M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $20.79M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $39.84M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $23.68M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $18.16M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $7.36M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 10.45M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $22K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.23M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $15.15M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $17.81M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.30 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.30 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.57M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$3.16M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$3.36M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$223K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $410K |
| Revenue | Q1 2025 · Mar 31, 2024 | $187K |